Form 8-K - Current report:
SEC Accession No. 0001213900-26-072137
Filing Date
2026-06-25
Accepted
2026-06-25 17:12:22
Documents
12
Period of Report
2026-06-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0295947-8k_rocket.htm   iXBRL 8-K 25342
2 PRESS RELEASE OF ROCKET ONE INC. DATED JUNE 25, 2026 ea029594701ex99-1.htm EX-99.1 11126
  Complete submission text file 0001213900-26-072137.txt   205468

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE rkto-20260624.xsd EX-101.SCH 3023
4 XBRL LABEL FILE rkto-20260624_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE rkto-20260624_pre.xml EX-101.PRE 22364
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0295947-8k_rocket_htm.xml XML 3195
Mailing Address 720 MONROE STREET SUITE E514 HOBOKEN NJ 07030
Business Address 720 MONROE STREET SUITE E514 HOBOKEN NJ 07030 (646)756-2997
Rocket One Inc. (Filer) CIK: 0001711786 (see all company filings)

EIN.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38803 | Film No.: 261122995
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)